Abstract

Growth hormone (GH) acts in both early and late follicular development to stimulate the proliferation and differentiation of granulosa cells and increase the production of estradiol in animal and human ovaries1-3. Fertility specialists have therefore explored the potential for GH supplementation to improve outcomes in women undergoing in vitro fertilization (IVF), with the greatest interest in women with diminished ovarian reserve, for whom successful fertilization remains a therapeutic challenge4.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.